PSIVIDA CORP. - Announcements

Currently unlisted. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

PVA	Change of Director's Interest Notice		15/12/16	71.44KB	Share
PVA	Change of Director's Interest Notice		15/12/16	65.16KB	Share
PVA	Initial Director's Interest Notice		15/12/16	43.83KB	Share
PVA	Form 4 - Jay Duker		15/12/16	183.88KB	Share
PVA	Form 4 - Michael Rogers		15/12/16	182.94KB	Share
PVA	Form 4 - Douglas Godshall		15/12/16	183.42KB	Share
PVA	Form 4 - Nancy Lurker		15/12/16	184.07KB	Share
PVA	Form 4 - James Barry		15/12/16	183.48KB	Share
PVA	Form 4-David Mazzo		15/12/16	183.77KB	Share
PVA	Appendix 3B		02/12/16	336.58KB	Share
PVA	Disclosure Document		09/11/16	780.33KB	Share
PVA	Disclosure Document	PRICE SENSITIVE	09/11/16	131.53KB	Share
PVA	Form 8-K Disclosure Document		08/11/16	193.32KB	Share
PVA	Seasoned Ophthalmology Executive Deb Jorn Joins pSivida to F		08/11/16	325.53KB	Share
PVA	pSivida Corp. Reports Fiscal 2017 First Quarter Results	PRICE SENSITIVE	08/11/16	354.98KB	Share
PVA	SEC Form 4 Statement of Beneficial Ownership		07/11/16	152.18KB	Share
PVA	Appendix 3B-PSDV.O		02/11/16	335.54KB	Share
PVA	pSivida Corp. Announces First Quarter Fiscal Year 2017 Finan-PSDV.O		01/11/16	324.1KB	Share
PVA	Notice of General Meeting/Proxy Form-PSDV.O		27/10/16	424.81KB	Share
PVA	Appendix 3B-PSDV.O		26/10/16	336.52KB	Share
PVA	Disclosure Document-PSDV.O	PRICE SENSITIVE	05/10/16	371.02KB	Share
PVA	PSIVIDA CORP. STRENGTHENS BOARD OF DIRECTORS-PSDV.O		28/09/16	328.51KB	Share
PVA	pSivida to Present at the Ladenburg Thalmann Annual Healthca-PSDV.O		23/09/16	362.29KB	Share
PVA	Final Director's Interest Notice-PSDV.O		22/09/16	64.66KB	Share
PVA	Initial Director's Interest Notice-PSDV.O		22/09/16	44.07KB	Share
PVA	pSivida Reports Inducement Awards to New President and CEO-PSDV.O	PRICE SENSITIVE	21/09/16	334.17KB	Share
PVA	Nancy Lurker named president CEO of pSivida-PSDV.O	PRICE SENSITIVE	16/09/16	347.75KB	Share
PVA	pSivida 10K as filed with US SEC-PSDV.O	PRICE SENSITIVE	14/09/16	743.06KB	Share
PVA	pSivida provides company update and reports Q4 and FY 2016-PSDV.O	PRICE SENSITIVE	13/09/16	266.24KB	Share
PVA	Appendix 3B-PSDV.O		07/09/16	336.31KB	Share
PVA	pSivida Announces 4th Q and FY 2016 Financial Results Releas-PSDV.O		02/09/16	136.38KB	Share
PVA	pSivida announces 13 New patents issued or allowed-PSDV.O	PRICE SENSITIVE	30/08/16	458.3KB	Share
PVA	First P3 results of pSivida's Medidur presented at ASRS meet-PSDV.O		16/08/16	357.67KB	Share
PVA	Primary Endpoint Met in pSivida's Utilization Study of Inser-PSDV.O	PRICE SENSITIVE	10/08/16	448.43KB	Share
PVA	SEC Form 3 Initital Statement of beneficial ownership-PSDV.O		04/08/16	167.82KB	Share
PVA	SEC Form 4 Statement of Beneficial Ownership-PSDV.O		04/08/16	151.46KB	Share
PVA	Appendix 3B-PSDV.O		04/08/16	333.65KB	Share
PVA	pSivida names industry vet as new Chief Medical Officer-PSDV.O		04/08/16	364.9KB	Share
PVA	pSivida & HSS announce opening of IND for OA-PSDV.O	PRICE SENSITIVE	02/08/16	372.7KB	Share
PVA	SEC Form 4 disclosure for Len Ross-PSDV.O		28/07/16	99.9KB	Share
PVA	Medidur maintains same high statistical significance at 12 m-PSDV.O	PRICE SENSITIVE	28/07/16	473.73KB	Share
PVA	SEC Form 4 disclosure for Lori Freedman-PSDV.O		28/07/16	100.79KB	Share
PVA	pSivida's Tethadur data presented at CRS Meeting-PSDV.O		21/07/16	379.22KB	Share
PVA	Announces Plan to Consolidate all R&D in current US Facility-PSDV.O	PRICE SENSITIVE	18/07/16	344.09KB	Share
PVA	Investigator-Sponsored P2 study results-PSDV.O	PRICE SENSITIVE	15/07/16	467.66KB	Share
PVA	pSivida announces poster and oral presentation-PSDV.O		11/07/16	355.18KB	Share
PVA	pSivida announces preclinical data for TKIs in wet AMD-PSDV.O	PRICE SENSITIVE	06/07/16	446.4KB	Share
PVA	Appendix 3B-PSDV.O		05/07/16	249KB	Share
PVA	Appendix 3B-PSDV.O		02/06/16	2.56MB	Share
PVA	pSivida 10Q for 3/31/16 as filed with US SEC-PSDV.O		09/05/16	284.75KB	Share
PVA	pSivida provides Co update and reports 3Q FY 16 results-PSDV.O	PRICE SENSITIVE	06/05/16	243.58KB	Share
PVA	Appendix 3B-PSDV.O		05/05/16	2.51MB	Share
PVA	pSivida CEO to present at 2016 International Symposium-PSDV.O		05/05/16	214.65KB	Share
PVA	Medidur for uveitis granted orphan drug designation in Europ-PSDV.O	PRICE SENSITIVE	03/05/16	373.7KB	Share
PVA	pSivida announces date and time of 3Q 2016 financial results-PSDV.O		28/04/16	207.36KB	Share
PVA	Appendix 3B-PSDV.O		06/04/16	231.99KB	Share
PVA	pSivida to present at Sidoti Spring 2016 Emerging Growth Con		29/03/16	134.43KB	Share
PVA	pSivida CEO Acquires Shares		23/03/16	153.92KB	Share
PVA	Additional Favorable 6-month safety results for Medidur	PRICE SENSITIVE	16/03/16	235.62KB	Share
PVA	Appendix 3B		02/03/16	2.53MB	Share
PVA	Final Director's Interest Notice		11/02/16	405.61KB	Share
PVA	Corporate Governance Report		10/02/16	731.75KB	Share
PVA	Half Yearly Report and Accounts	PRICE SENSITIVE	10/02/16	484.09KB	Share
PVA	Director Appointment/Resignation		09/02/16	86.49KB	Share
PVA	pSivida Corp. Provides Co Update and Reports Q2 FY 2016 resu	PRICE SENSITIVE	09/02/16	244.74KB	Share
PVA	pSivida announces 2Q FY 16 Financial Results release date		02/02/16	203.84KB	Share
PVA	Appendix 3B		02/02/16	230.72KB	Share
PVA	pSivida CEO to present at 18th Annual Bio CEO & Investor Con		29/01/16	208.8KB	Share
PVA	pSivida Closes $17.8 Million Offering	PRICE SENSITIVE	14/01/16	135.6KB	Share
PVA	8K document filed with US SEC		11/01/16	307.72KB	Share
PVA	prospectus supplement as filed with US SEC	PRICE SENSITIVE	11/01/16	163KB	Share
PVA	pSivida announces pricing of $16 Million public offering of	PRICE SENSITIVE	08/01/16	134.39KB	Share
PVA	Trading Halt	PRICE SENSITIVE	07/01/16	250.27KB	Share
PVA	pSivida Announces Proposed Public Offering of Common Stock	PRICE SENSITIVE	07/01/16	133.38KB	Share
PVA	SEC Form 4 Change in Insider holdings		06/01/16	154.13KB	Share
PVA	Appendix 3B		05/01/16	2.54MB	Share
PVA	pSivida Plans to Apply for EU Approval with Single P3 Trial	PRICE SENSITIVE	29/12/15	303.68KB	Share
PVA	Ross Leonards SEC Form 4 - Changes in Beneficial Ownership		24/12/15	154.12KB	Share
PVA	Paul Ashton SEC Form 4 - Changes in Beneficial Ownership		24/12/15	155.56KB	Share
PVA	Medidur P3 Meets Primary Efficacy Endpoint	PRICE SENSITIVE	23/12/15	323.87KB	Share
PVA	Change of Director's Interest Notice		07/12/15	778.79KB	Share
PVA	Change of Director's Interest Notice		07/12/15	683.21KB	Share
PVA	Change of Director's Interest Notice		07/12/15	682.54KB	Share
PVA	Change of Director's Interest Notice		07/12/15	689.17KB	Share
PVA	Change of Director's Interest Notice		07/12/15	619.21KB	Share
PVA	Change of Director's Interest Notice		07/12/15	560.53KB	Share
PVA	SEC Form 4 - Paul Ashton options granted		07/12/15	151.16KB	Share
PVA	SEC Form 4 - David Mazzo options granted		07/12/15	151.93KB	Share
PVA	SEC Form 4 - Peter Savas options granted		07/12/15	151.2KB	Share
PVA	SEC Form 4 - Michael Rogers options granted		07/12/15	151.16KB	Share
PVA	SEC Form 4 - James Barry options granted		07/12/15	151.45KB	Share
PVA	SEC Form 4 Doug Godshall Director options granted		07/12/15	151.28KB	Share
PVA	Results of Meeting		07/12/15	111.16KB	Share
PVA	SEC Form 4 - Changes in Beneficial Ownership Len Ross		04/12/15	153.9KB	Share
PVA	Appendix 3B		02/12/15	2.5MB	Share
PVA	S3 Registration statement filed with US SEC	PRICE SENSITIVE	20/11/15	390.81KB	Share
PVA	Disclosure Document		11/11/15	258.01KB	Share
PVA	pSivida provides company update and reports first quarter re	PRICE SENSITIVE	06/11/15	242.15KB	Share
PVA	Appendix 3B		05/11/15	2.49MB	Share
PVA	pSivida Announces Q1 FY 2016 financial results release date		02/11/15	205.24KB	Share

PVA Change of Director's Interest Notice
15/12/16		71.44KB	Share
PVA Change of Director's Interest Notice
15/12/16		65.16KB	Share
PVA Initial Director's Interest Notice
15/12/16		43.83KB	Share
PVA Form 4 - Jay Duker
15/12/16		183.88KB	Share
PVA Form 4 - Michael Rogers
15/12/16		182.94KB	Share
PVA Form 4 - Douglas Godshall
15/12/16		183.42KB	Share
PVA Form 4 - Nancy Lurker
15/12/16		184.07KB	Share
PVA Form 4 - James Barry
15/12/16		183.48KB	Share
PVA Form 4-David Mazzo
15/12/16		183.77KB	Share
PVA Appendix 3B
02/12/16		336.58KB	Share
PVA Disclosure Document
09/11/16		780.33KB	Share
PVA Disclosure Document
09/11/16	PRICE SENSITIVE	131.53KB	Share
PVA Form 8-K Disclosure Document
08/11/16		193.32KB	Share
PVA Seasoned Ophthalmology Executive Deb Jorn Joins pSivida to F
08/11/16		325.53KB	Share
PVA pSivida Corp. Reports Fiscal 2017 First Quarter Results
08/11/16	PRICE SENSITIVE	354.98KB	Share
PVA SEC Form 4 Statement of Beneficial Ownership
07/11/16		152.18KB	Share
PVA Appendix 3B-PSDV.O
02/11/16		335.54KB	Share
PVA pSivida Corp. Announces First Quarter Fiscal Year 2017 Finan-PSDV.O
01/11/16		324.1KB	Share
PVA Notice of General Meeting/Proxy Form-PSDV.O
27/10/16		424.81KB	Share
PVA Appendix 3B-PSDV.O
26/10/16		336.52KB	Share
PVA Disclosure Document-PSDV.O
05/10/16	PRICE SENSITIVE	371.02KB	Share
PVA PSIVIDA CORP. STRENGTHENS BOARD OF DIRECTORS-PSDV.O
28/09/16		328.51KB	Share
PVA pSivida to Present at the Ladenburg Thalmann Annual Healthca-PSDV.O
23/09/16		362.29KB	Share
PVA Final Director's Interest Notice-PSDV.O
22/09/16		64.66KB	Share
PVA Initial Director's Interest Notice-PSDV.O
22/09/16		44.07KB	Share
PVA pSivida Reports Inducement Awards to New President and CEO-PSDV.O
21/09/16	PRICE SENSITIVE	334.17KB	Share
PVA Nancy Lurker named president CEO of pSivida-PSDV.O
16/09/16	PRICE SENSITIVE	347.75KB	Share
PVA pSivida 10K as filed with US SEC-PSDV.O
14/09/16	PRICE SENSITIVE	743.06KB	Share
PVA pSivida provides company update and reports Q4 and FY 2016-PSDV.O
13/09/16	PRICE SENSITIVE	266.24KB	Share
PVA Appendix 3B-PSDV.O
07/09/16		336.31KB	Share
PVA pSivida Announces 4th Q and FY 2016 Financial Results Releas-PSDV.O
02/09/16		136.38KB	Share
PVA pSivida announces 13 New patents issued or allowed-PSDV.O
30/08/16	PRICE SENSITIVE	458.3KB	Share
PVA First P3 results of pSivida's Medidur presented at ASRS meet-PSDV.O
16/08/16		357.67KB	Share
PVA Primary Endpoint Met in pSivida's Utilization Study of Inser-PSDV.O
10/08/16	PRICE SENSITIVE	448.43KB	Share
PVA SEC Form 3 Initital Statement of beneficial ownership-PSDV.O
04/08/16		167.82KB	Share
PVA SEC Form 4 Statement of Beneficial Ownership-PSDV.O
04/08/16		151.46KB	Share
PVA Appendix 3B-PSDV.O
04/08/16		333.65KB	Share
PVA pSivida names industry vet as new Chief Medical Officer-PSDV.O
04/08/16		364.9KB	Share
PVA pSivida & HSS announce opening of IND for OA-PSDV.O
02/08/16	PRICE SENSITIVE	372.7KB	Share
PVA SEC Form 4 disclosure for Len Ross-PSDV.O
28/07/16		99.9KB	Share
PVA Medidur maintains same high statistical significance at 12 m-PSDV.O
28/07/16	PRICE SENSITIVE	473.73KB	Share
PVA SEC Form 4 disclosure for Lori Freedman-PSDV.O
28/07/16		100.79KB	Share
PVA pSivida's Tethadur data presented at CRS Meeting-PSDV.O
21/07/16		379.22KB	Share
PVA Announces Plan to Consolidate all R&D in current US Facility-PSDV.O
18/07/16	PRICE SENSITIVE	344.09KB	Share
PVA Investigator-Sponsored P2 study results-PSDV.O
15/07/16	PRICE SENSITIVE	467.66KB	Share
PVA pSivida announces poster and oral presentation-PSDV.O
11/07/16		355.18KB	Share
PVA pSivida announces preclinical data for TKIs in wet AMD-PSDV.O
06/07/16	PRICE SENSITIVE	446.4KB	Share
PVA Appendix 3B-PSDV.O
05/07/16		249KB	Share
PVA Appendix 3B-PSDV.O
02/06/16		2.56MB	Share
PVA pSivida 10Q for 3/31/16 as filed with US SEC-PSDV.O
09/05/16		284.75KB	Share
PVA pSivida provides Co update and reports 3Q FY 16 results-PSDV.O
06/05/16	PRICE SENSITIVE	243.58KB	Share
PVA Appendix 3B-PSDV.O
05/05/16		2.51MB	Share
PVA pSivida CEO to present at 2016 International Symposium-PSDV.O
05/05/16		214.65KB	Share
PVA Medidur for uveitis granted orphan drug designation in Europ-PSDV.O
03/05/16	PRICE SENSITIVE	373.7KB	Share
PVA pSivida announces date and time of 3Q 2016 financial results-PSDV.O
28/04/16		207.36KB	Share
PVA Appendix 3B-PSDV.O
06/04/16		231.99KB	Share
PVA pSivida to present at Sidoti Spring 2016 Emerging Growth Con
29/03/16		134.43KB	Share
PVA pSivida CEO Acquires Shares
23/03/16		153.92KB	Share
PVA Additional Favorable 6-month safety results for Medidur
16/03/16	PRICE SENSITIVE	235.62KB	Share
PVA Appendix 3B
02/03/16		2.53MB	Share
PVA Final Director's Interest Notice
11/02/16		405.61KB	Share
PVA Corporate Governance Report
10/02/16		731.75KB	Share
PVA Half Yearly Report and Accounts
10/02/16	PRICE SENSITIVE	484.09KB	Share
PVA Director Appointment/Resignation
09/02/16		86.49KB	Share
PVA pSivida Corp. Provides Co Update and Reports Q2 FY 2016 resu
09/02/16	PRICE SENSITIVE	244.74KB	Share
PVA pSivida announces 2Q FY 16 Financial Results release date
02/02/16		203.84KB	Share
PVA Appendix 3B
02/02/16		230.72KB	Share
PVA pSivida CEO to present at 18th Annual Bio CEO & Investor Con
29/01/16		208.8KB	Share
PVA pSivida Closes $17.8 Million Offering
14/01/16	PRICE SENSITIVE	135.6KB	Share
PVA 8K document filed with US SEC
11/01/16		307.72KB	Share
PVA prospectus supplement as filed with US SEC
11/01/16	PRICE SENSITIVE	163KB	Share
PVA pSivida announces pricing of $16 Million public offering of
08/01/16	PRICE SENSITIVE	134.39KB	Share
PVA Trading Halt
07/01/16	PRICE SENSITIVE	250.27KB	Share
PVA pSivida Announces Proposed Public Offering of Common Stock
07/01/16	PRICE SENSITIVE	133.38KB	Share
PVA SEC Form 4 Change in Insider holdings
06/01/16		154.13KB	Share
PVA Appendix 3B
05/01/16		2.54MB	Share
PVA pSivida Plans to Apply for EU Approval with Single P3 Trial
29/12/15	PRICE SENSITIVE	303.68KB	Share
PVA Ross Leonards SEC Form 4 - Changes in Beneficial Ownership
24/12/15		154.12KB	Share
PVA Paul Ashton SEC Form 4 - Changes in Beneficial Ownership
24/12/15		155.56KB	Share
PVA Medidur P3 Meets Primary Efficacy Endpoint
23/12/15	PRICE SENSITIVE	323.87KB	Share
PVA Change of Director's Interest Notice
07/12/15		778.79KB	Share
PVA Change of Director's Interest Notice
07/12/15		683.21KB	Share
PVA Change of Director's Interest Notice
07/12/15		682.54KB	Share
PVA Change of Director's Interest Notice
07/12/15		689.17KB	Share
PVA Change of Director's Interest Notice
07/12/15		619.21KB	Share
PVA Change of Director's Interest Notice
07/12/15		560.53KB	Share
PVA SEC Form 4 - Paul Ashton options granted
07/12/15		151.16KB	Share
PVA SEC Form 4 - David Mazzo options granted
07/12/15		151.93KB	Share
PVA SEC Form 4 - Peter Savas options granted
07/12/15		151.2KB	Share
PVA SEC Form 4 - Michael Rogers options granted
07/12/15		151.16KB	Share
PVA SEC Form 4 - James Barry options granted
07/12/15		151.45KB	Share
PVA SEC Form 4 Doug Godshall Director options granted
07/12/15		151.28KB	Share
PVA Results of Meeting
07/12/15		111.16KB	Share
PVA SEC Form 4 - Changes in Beneficial Ownership Len Ross
04/12/15		153.9KB	Share
PVA Appendix 3B
02/12/15		2.5MB	Share
PVA S3 Registration statement filed with US SEC
20/11/15	PRICE SENSITIVE	390.81KB	Share
PVA Disclosure Document
11/11/15		258.01KB	Share
PVA pSivida provides company update and reports first quarter re
06/11/15	PRICE SENSITIVE	242.15KB	Share
PVA Appendix 3B
05/11/15		2.49MB	Share
PVA pSivida Announces Q1 FY 2016 financial results release date
02/11/15		205.24KB	Share

REFRESH

First 2 3 4 5 6

PSIVIDA CORP. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available